We are live on ! Find out more

AMBQ

Ambiq Micro

AMBQ

Market cap $1.72B

71.09 USD

+5.63

8.6%

At close Updated Sep 21, 4:00 PM EDT

Pre-market

After hours

72.89

+1.80

2.53%

1 day

8.6%

5 days

17.21%

1 month

20.45%

3 months

-19.73%

6 months

180.32%

Year to date

134.23%

1 year

121.74%

5 years

84.51%

10 years

84.51%

About: Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the power consumption challenges of general purpose and AI compute - especially at the edge. The company provides a full-stack solution encompassing tightly integrated hardware and software. Its solutions include a diverse family of systems-on-chip (SoCs) and the software required to enable on-chip AI processing, general compute, sensing, security, storage, wireless connectivity, and developed graphics.

Employees: 202

Technology Semiconductors

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 26.3%

Neutral 57.9%

Negative 15.8%

Zacks Investment Research

Why Is Ambiq Micro, Inc. (AMBQ) Down 2.8% Since Last Earnings Report?

Ambiq Micro, Inc. (AMBQ) reported earnings 30 days ago. What's next for the stock?

Why Is Ambiq Micro, Inc. (AMBQ) Down 2.8% Since Last Earnings Report?

Zacks Investment Research

Does Ambiq Micro, Inc. (AMBQ) Have the Potential to Rally 40.96% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 41% in Ambiq Micro, Inc. (AMBQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Does Ambiq Micro, Inc. (AMBQ) Have the Potential to Rally 40.96% as Wall Street Analysts Expect?

Zacks Investment Research

Ambiq's Q2 Earnings Surpass Estimates, Revenues Rise Y/Y

AMBQ's Q2 earnings beat estimates as Edge AI demand drives an 89.7% revenue surge, while margins expand and growth stays strong.

Ambiq's Q2 Earnings Surpass Estimates, Revenues Rise Y/Y

Ambiq Micro Analysts Increase Their Forecasts After Strong Q2 Results

Ambiq Micro Inc (NASDAQ:AMBQ) on Tuesday reported better-than-expected second-quarter financial results and issued strong third-quarter guidance.

Ambiq Micro Analysts Increase Their Forecasts After Strong Q2 Results

Ambiq Micro, Inc. (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro, Inc. (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro, Inc. (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro Q2 Earnings Call Highlights

Ambiq Micro NYSE: AMBQ reported second-quarter 2026 net sales of $33.9 million, up 89.7% from a year earlier, as demand for edge artificial intelligence applications accelerated across its customer base and product portfolio.

Ambiq Micro Q2 Earnings Call Highlights

Zacks Investment Research

Ambiq Micro, Inc. (AMBQ) Reports Q2 Loss, Tops Revenue Estimates

Ambiq Micro, Inc. (AMBQ) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.43 per share a year ago.

Ambiq Micro, Inc. (AMBQ) Reports Q2 Loss, Tops Revenue Estimates

Investors Business Daily

Ambiq Micro Stock Rises On Chipmaker's Beat-And-Raise Report

Ambiq Micro beat analyst estimates for the second quarter and with its guidance for the third quarter. Ambiq stock rose on the news.

Ambiq Micro Stock Rises On Chipmaker's Beat-And-Raise Report

Ambiq Reports Second Quarter 2026 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)---- $AMBQ #AI--Ambiq Reports Second Quarter 2026 Financial Results.

Ambiq Reports Second Quarter 2026 Financial Results

Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors

The leading contributor was Ambiq Micro, Inc. (AMBQ) , a designer of ultra-low power semiconductor solutions that went public in July of 2025. Suncrete's stock moved higher in the wake of strong first quarter revenue growth. TriSalus posted a significant miss on revenues and lowered guidance during the quarter, citing the impact of a Salesforce (CRM) reorganization and delayed FDA review of its next-generation device.

Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors

See News Rankings

Price charts implemented using Lightweight Charts™